Both in Biotechnology
Solid Biosciences vs Attovia Therapeutics
Over the past year SLDB returned −25.7% and ATTO returned −34.3%; their daily moves had a correlation of 0.35.
SLDB −25.7% ATTO −34.3%Growth of $1, one year, split-adjusted
| Metric | SLDB | ATTO |
|---|---|---|
| Price | $6.47 | $14.97 |
| Market cap | $693.2M | $683.4M |
| Today | +2.95% | −1.96% |
| 1 month | −6.6% | −14.5% |
| 6 months | −10.2% | — |
| Year to date | +14.6% | — |
| 1 year | +24.3% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $377.7M | — |
| Dividend yield | — | — |
| Volatility (60d) | 68.2% | — |
| Short % of float | 17.8% | 5.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).